After nearly two years of sustained correction in pharmaceutical stocks, valuations across the sector have eased to more reasonable levels, prompting Elara Securities to adopt a constructive stance on select names within the space.Elara’s Preferred Pharma Picks
Elara Securities has identified...
Silver Rally Enters Structural Phase as Volatility Tests Investor Conviction, Says Apurva Sheth
Technical Compression, Undervaluation and Macro Tailwinds Drove Early Call
Silver’s rally over the past year has reignited investor interest, marked by sharp upward moves followed by equally swift...
Heightened market volatility has triggered a broad correction in equity valuations, with several stocks retreating from the steep premiums they commanded just months ago. However, according to Deven Choksey, Managing Director at DRChoksey Finserv, this phase of consolidation is helping restore...
